Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kartik Prabhakaran

Surgical Critical Care Valhalla, NY Medical Doctor

NPI 1982986980 CMS profile 1294599

100 Woods Rd, Valhalla, NY 10595

Open in the dashboard

General payments

$21,708

75 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$74,722 paid to institutions, not to them · program years 2023–2025

Through program year 2025, Kartik Prabhakaran of Valhalla, NY is reported in the CMS Open Payments database as having received $21,708 across 75 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $74,722 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 94th percentile of Surgical Critical Care profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,225 14
2024 General $1,815 13
2023 General $18,450 43
2022 General $56 3
2019 General $162 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kartik Prabhakaran
  • Surgical Critical Care median
  • Middle half of Surgical Critical Care
  • National median

In program year 2025, general payments to Kartik Prabhakaran were reported at $1,225. Among 1,068 Surgical Critical Care profiles paid that year, the median was $231 and the middle half received between $82 and $1,489.

Show as a table
Year Kartik Prabhakaran Surgical Critical Care median Middle half National median
2019 $162 $161 $57–$631 $163
2020 $0 $116 $33–$383 $114
2021 $0 $121 $37–$475 $132
2022 $56 $163 $53–$789 $149
2023 $18,450 $188 $67–$1,031 $160
2024 $1,815 $216 $80–$1,133 $164
2025 $1,225 $231 $82–$1,489 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $18,489 41 payments
  2. Kerecis Limited $859 5 payments
  3. Dilon Technologies, Inc. $547 5 payments
  4. Zimmer Biomet Holdings, Inc. $431 4 payments
  5. AbbVie, Inc. $418 5 payments
  6. Davol Inc. $251 3 payments
  7. Access Pro Medical, LLC $182 1 payment
  8. Allergan Inc. $162 2 payments
  9. PolyNovo North America LLC $115 1 payment
  10. W. L. Gore & Associates, Inc. $83 1 payment
  11. Other $171 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $8,608 8 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $5,500 5 payments
  3. Food and Beverage $3,803 44 payments
  4. Travel and Lodging $3,781 17 payments
  5. Gift $16 1 payment
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $9,489 37 payments
  2. DAVINCI XI $8,500 3 payments
  3. Kerecis Omega3 SurgiClose Wound Care $772 4 payments
  4. HEMOBLAST BELLOWS $547 5 payments
  5. DA VINCI SP $500 1 payment
  6. Kerecis Omega3 GraftGuide $466 2 payments
  7. Kerecis Omega3 SurgiClose Wound Care $447 1 payment
  8. Kerecis Omega3 Marigen $447 1 payment
  9. Kerecis Omega3 SurgiClose Wound Care $447 1 payment
  10. STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS $418 5 payments
  11. Other $3,569 45 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 35 billing codes

Paid by Medicare

$58,834

Medicare's payments for the services billed

Medicare patients

205

Average age 77

Services billed

445

103 women, 102 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 59%
Ischemic heart disease 49%
Diabetes 40%
Atrial fibrillation 36%
Chronic kidney disease 32%
Heart failure 29%
Depression 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Kcentra
  • CSL Behring $20
$20 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

75 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgical Critical Care in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record